New insights into paroxysmal nocturnal hemoglobinuria

Hematology

Volumn 12, Issue 5, 2007, Pages 371-376

  Savage, William J ^a   Brodsky, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eculizumab; Nitric oxide; Paroxysmal nocturnal hemoglobinuria; PIG A

Indexed keywords

AEROLYSIN; ECULIZUMAB; GLYCOSYLPHOSPHATIDYLINOSITOL; HEMOGLOBIN; NITRIC OXIDE; PLACEBO; VACCINE;

ABDOMINAL PAIN; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACKACHE; CLINICAL FEATURE; CLINICAL TRIAL; ERECTILE DYSFUNCTION; ERYTHROCYTE TRANSFUSION; ESOPHAGUS SPASM; FATIGUE; FLOW CYTOMETRY; HEADACHE; HUMAN; INTRAVASCULAR HEMOLYSIS; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTION; NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; QUALITY OF LIFE; RHINOPHARYNGITIS; THROMBOPHILIA; THROMBOSIS; UPPER RESPIRATORY TRACT INFECTION;

ANTIBODIES, MONOCLONAL; GLYCOSYLPHOSPHATIDYLINOSITOLS; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HUMANS; NITRIC OXIDE;

EID: 34748927011     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330701562634     Document Type: Article

References (40)

1. Takeda, J., Miyata, T. and Kawagoe, K. (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell, 73:4, pp. 703-711.
2. Hillmen, P., Lewis, SM and Bessler, M. (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med, 333:19, pp. 1253-1258.
3. Hillmen, P., Young, NS and Schubert, J. (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med, 355:12, pp. 1233-1243.
4. Bessler, M., Mason, PJ and Hillmen, P. (1994) Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J, 13:1, pp. 110-117.
5. Nagarajan, S., Brodsky, RA and Young, NS (1995) Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood, 86:12, pp. 4656-4661.
6. Pramoonjago, P., Pakdeesuwan, K. and Siripanyaphinyo, U. (1999) Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol, 105:2, pp. 497-504.
7. Nafa, K., Mason, PJ and Hillmen, P. (1995) Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood, 86:12, pp. 4650-4655.
8. Yamada, N., Miyata, T. and Maeda, K. (1995) Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood, 85:4, pp. 885-892.
9. Chen, R., Nagarajan, S. and Prince, GM (2000) Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria. J Clin Invest, 106:5, pp. 689-696.
10. Rollins, SA and Sims, PJ (1990) The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol, 144:9, pp. 3478-3483.
11. Medof, ME, Kinoshita, T. and Silber, R. (1985) Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci USA, 82:9, pp. 2980-2984.
12. Wilcox, LA, Ezzell, JL and Bernshaw, NJ (1991) Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Blood, 78:3, pp. 820-829.
13. Rother, RP, Bell, L. and Hillmen, P. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA, 293:13, pp. 1653-1662.
14. Tailor, A., Cooper, D. and Granger, DN (2005) Platelet-vessel wall interactions in the microcirculation. Microcirculation, 12:3, pp. 275-285.
15. Reiter, CD, Wang, X. and Tanus-Santos, JE (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med, 8:12, pp. 1383-1389.
16. Moyo, VM, Mukhina, GL and Garrett, ES (2004) Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol, 126:1, pp. 133-138.
17. Carmichael, FJ, Ali, AC and Campbell, JA (2000) A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med, 28:7, pp. 2283-2292.
18. Savitsky, JP, Doczi, J. and Black, J. (1978) A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther, 23:1, pp. 73-80.
19. Saxena, R., Wijnhoud, AD and Carton, H. (1999) Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke, 30:5, pp. 993-996.
20. Tziros, C. and Freedman, JE (2006) The many antithrombotic actions of nitric oxide. Curr Drug Targets, 7:10, pp. 1243-1251.
21. Hugel, B. and Socie, G. (1999) Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood, 93:10, pp. 3451-3456.
22. Grunewald, M., Siegemund, A. and Grunewald, A. (2003) Plasmatic coagulation and fibrinolytic system alterations in PNH: Relation to clone size. Blood Coagul Fibrinolysis, 14:7, pp. 685-695.
23. Maroney, SA, Cunningham, AC and Ferrel, J. (2006) A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression. J Thromb Haemost, 4:5, pp. 1114-1124.
24. Araten, DJ, Nafa, K. and Pakdeesuwan, K. (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA, 96:9, pp. 5209-5214.
25. Mukhina, GL and Piantadosi, S. (2005) PIG-A mutations in normal hematopoiesis. Blood, 105:10, pp. 3848-3854.
26. Rosti, V., Tremml, G. and Soares, V. (1997) Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest, 100:5, pp. 1028-1036.
27. Kawagoe, K., Kitamura, D. and Okabe, M. (1996) Glycosylphosphatidylinositol-anchor-deficient mice: Implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood, 87:9, pp. 3600-3606.
28. Brodsky, RA, Vala, MS and Barber, JP (1997) Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA, 94:16, pp. 8756-8760.
29. Hanaoka, N., Kawaguchi, T. and Horikawa, K. (2006) Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP. Blood, 107:3, pp. 1184-1191.
30. Inoue, N., Izui-Sarumaru, T. and Murakami, Y. (2006) Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood, 108:13, pp. 4232-4236.
31. Wang, H., Chuhjo, T. and Yamazaki, H. (2001) Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: The high prevalence at diagnosis. Eur J Haematol, 66:3, pp. 200-205.
32. Mukhina, GL, Buckley, JT and Barber, JP (2001) Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol, 115:2, pp. 476-482.
33. Dunn, DE, Tanawattanacharoen, P. and Boccuni, P. (1999) Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med, 131:6, pp. 401-408.
34. Hernandez-Campo, PM, Almeida, J. and Sanchez, ML (2006) Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: A frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry B Clin Cytom, 70:2, pp. 71-81.
35. Brodsky, RA and Mukhina, GL (2000) Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol, 114:3, pp. 459-466.
36. Saso, R., Marsh, J. and Cevreska, L. (1999) Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol, 104:2, pp. 392-396.
37. Hegenbart, U., Niederwieser, D. and Forman, S. (2003) Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant, 9:11, pp. 689-697.
38. Takahashi, Y., McCoy Jr., JP and Carvallo, C. (2004) In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood, 103:4, pp. 1383-1390.
39. Kawahara, K., Witherspoon, RP and Storb, R. (1992) Marrow transplantation for paroxysmal nocturnal hemoglobinuria. Am J Hematol, 39:4, pp. 283-288.
40. Hillmen, P., Hall, C. and Marsh, JC (2004) Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med, 350:6, pp. 552-559.